| 1 |
Chen H, Xu S, Hu Z, Wei Y, Zhu Y, Fang S, Pan Q, Liu K, Li N, Zhu L, Xu G. Bioinformatics algorithm for lung adenocarcinoma based on macropinocytosis-related long noncoding RNAs as a reliable indicator for predicting survival outcomes and selecting suitable anti-tumor drugs. Medicine (Baltimore) 2022;101:e30543. [PMID: 36197217 DOI: 10.1097/MD.0000000000030543] [Reference Citation Analysis]
|
| 2 |
Liu Y, Yu M, Cheng X, Zhang X, Luo Q, Liao S, Chen Z, Zheng J, Long K, Wu X, Qu W, Gong M, Song Y. A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs. Front Genet 2022;13:1016449. [DOI: 10.3389/fgene.2022.1016449] [Reference Citation Analysis]
|
| 3 |
Chan MK, Chung JY, Tang PC, Chan AS, Ho JY, Lin TP, Chen J, Leung K, To K, Lan H, Tang PM. TGF-β signaling networks in the tumor microenvironment. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.215925] [Reference Citation Analysis]
|
| 4 |
Yan Q, Hu B, Chen H, Zhu L, Lyu Y, Qian D, Shao G. A novel algorithm for lung adenocarcinoma based on N6 methyladenosine-related immune long noncoding RNAs as a reliable biomarker for predicting survival outcomes and selecting sensitive anti-tumor therapies. J Clin Lab Anal 2022;:e24636. [PMID: 35949000 DOI: 10.1002/jcla.24636] [Reference Citation Analysis]
|
| 5 |
Wang G, Liu P, Li J, Jin K, Zheng X, Xie L. Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma. Vaccines 2022;10:1161. [DOI: 10.3390/vaccines10071161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Chen H, Zhou C, Hu Z, Sang M, Ni S, Wu J, Pan Q, Tong J, Liu K, Li N, Zhu L, Xu G. Construction of an algorithm based on oncosis-related LncRNAs comprising the molecular subtypes and a risk assessment model in lung adenocarcinoma. J Clin Lab Anal 2022;:e24461. [PMID: 35476781 DOI: 10.1002/jcla.24461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Shen W, Tong D, Chen J, Li H, Hu Z, Xu S, He S, Ge Z, Zhang J, Mao Q, Chen H, Xu G. Silencing oncogene cell division cycle associated 5 induces apoptosis and G1 phase arrest of non‐small cell lung cancer cells via p53‐p21 signaling pathway. Clinical Laboratory Analysis. [DOI: 10.1002/jcla.24396] [Reference Citation Analysis]
|
